News Hub

Real-time financial, economic, and global news with market-focused context and analysis.

Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.

  • Palestinians voted in Deir al-Balah, Gaza, in local elections for the first time in two decades, testing PA’s claim to govern Gaza.
  • Beijing warned U.S. export-control bills risk destabilizing global chip supply chains and signaled possible protective measures for domestic firms.
  • Georgia declared a state emergency after wildfires burned roughly 39,500 acres and destroyed over 122 homes and buildings.
  • U.S. Southern Command said an Eastern Pacific strike killed two 'male narco-terrorists', prompting human-rights criticism and regional security concerns.
  • American Express beat Q1 profit estimates as billed business rose 9% and card spending hit a three-year high.
  • The EU approved a €90 billion loan to support Ukraine but warned of funding gaps and limited defense production capacity.
  • SpaceX's S-1 warns probes into xAI's sexualized AI images could restrict market access, adding regulatory risk before IPO.

Latest Articles

HMH Holding Inc. Announces Closing of Initial Public Offering

HMH Holding Inc. Announces Closing of Initial Public Offering

HMH Holding Inc., a provider of mission-critical drilling equipment and services for oil and gas operations, completed its initial public offering of 10.52 million Class A shares at $20.00 each, raising net proceeds of about $193.8 million. The shares commenced trading on The Nasdaq Global Select Market on April 1, 2026, under the symbol 'HMH'. The…

Annovis Secures U.S. Patent for Buntanetap in the Prevention and Treatment of Neurological Injuries Caused by Brain Infections

Annovis Secures U.S. Patent for Buntanetap in the Prevention and Treatment of Neurological Injuries Caused by Brain Infections

Annovis Bio announced it received a U.S. patent covering the use of its investigational drug buntanetap in preventing and treating neurological injuries caused by brain infections, including those linked to Alzheimer's disease. The patent extends through 2044 and covers both preventive and therapeutic applications against a range of infectious agen…

Plus Therapeutics Secures Highmark Coverage for CNSide® CSF Assay, Expanding Reimbursement to ~75 Million Covered Lives

Plus Therapeutics Secures Highmark Coverage for CNSide® CSF Assay, Expanding Reimbursement to ~75 Million Covered Lives

Plus Therapeutics, through its subsidiary CNSide Diagnostics, secured a reimbursement coverage agreement with Highmark for its CNSide CSF Tumor Cell Enumeration assay, increasing total covered lives from approximately 67 million to 75 million. This expands patient access and supports broader adoption of CNSide in the detection and monitoring of met…

Context Therapeutics Announces CTIM-76 Receives FDA Fast Track Designation for the Treatment of Platinum-Resistant Ovarian Cancer

Context Therapeutics Announces CTIM-76 Receives FDA Fast Track Designation for the Treatment of Platinum-Resistant Ovarian Cancer

Context Therapeutics announced that the FDA has granted Fast Track Designation to its investigational drug CTIM-76, a CLDN6 x CD3 T cell engaging bispecific antibody, aimed at treating platinum-resistant ovarian cancer. The company is conducting a Phase 1 clinical trial with interim data expected in June 2026. This designation could expedite the de…

MiNK Therapeutics to Present New Data at ASGCT 2026 Highlighting Context-Dependent Activity of iNKT Cell Therapy

MiNK Therapeutics to Present New Data at ASGCT 2026 Highlighting Context-Dependent Activity of iNKT Cell Therapy

MiNK Therapeutics disclosed that its investigational allogeneic iNKT cell therapy, agenT-797, will be featured at the ASGCT 2026 meeting. The therapy harnesses innate and adaptive immunity to target cancer, immune-mediated diseases, and severe pulmonary inflammation. The presentation underscores agenT-797's potential to modulate adaptive immune res…

FibroBiologics Announces Closing of $3 Million Public Offering

FibroBiologics Announces Closing of $3 Million Public Offering

FibroBiologics, a clinical-stage biotech company specializing in fibroblast-based therapeutics, closed a best efforts public offering raising approximately $3 million before fees. The offering included common stock and warrants exercisable upon stockholder approval, with potential additional proceeds of $3 million if warrants are exercised. Proceed…

CN Reports March Grain Movement

CN Reports March Grain Movement

CN reported moving over 2.96 million metric tonnes of grain from Western Canada in March 2026, setting a new record for the month and achieving the highest first quarter grain movement results ever. Despite late-month weather disruptions affecting terminal capacity, CN quickly restored network performance, supported by a strong export demand and th…

Esperion Therapeutics Closes Acquisition of Corstasis Therapeutics, Expanding Its Cardiovascular Franchise with Enbumyst™ (bumetanide nasal spray)

Esperion Therapeutics Closes Acquisition of Corstasis Therapeutics, Expanding Its Cardiovascular Franchise with Enbumyst™ (bumetanide nasal spray)

Esperion Therapeutics has finalized the acquisition of Corstasis Therapeutics, incorporating the FDA-approved Enbumyst nasal spray loop diuretic into its cardiovascular portfolio. This addition expands Esperion's treatment offerings for edema related to congestive heart failure and other conditions, enhancing outpatient care options and supporting …

Century Aluminum Applauds President Trump for Executive Order to Fully Enforce Sec. 232 Aluminum Tariffs

Century Aluminum Applauds President Trump for Executive Order to Fully Enforce Sec. 232 Aluminum Tariffs

Century Aluminum applauds President Trump's executive order to enforce Section 232 aluminum tariffs fully by closing valuation loopholes that importers exploited to reduce tariff payments. The 50% tariffs remain unchanged, and the order requires importers to declare the full value of aluminum products, supporting fair competition and benefiting dom…

Toll Brothers Honored at the New Jersey Builders Association Awards

Toll Brothers Honored at the New Jersey Builders Association Awards

Toll Brothers, Inc., a leading luxury home builder, announced its New Jersey division received 10 awards at the Sales and Marketing Awards presented by the New Jersey Builders Association. Awards include Community of the Year for Canter Square and Regency at Cranbury, Best Design Center, and several others recognizing excellence in sales, marketing…

Vericel Announces BARDA Award Valued at up to $197 Million for Procurement and Advanced Development of NexoBrid

Vericel Announces BARDA Award Valued at up to $197 Million for Procurement and Advanced Development of NexoBrid

Vericel Corporation has been awarded a 10-year contract valued at up to $197 million by the U.S. Biomedical Advanced Research and Development Authority (BARDA) for procurement and advanced development of NexoBrid, including establishing a U.S.-based manufacturing facility and developing next-generation formulations and new indications. This contrac…

EXL announces a strategic services collaboration with Google Cloud

EXL announces a strategic services collaboration with Google Cloud

EXL, a Nasdaq-listed global data and AI company, announced a strategic partnership with Google Cloud aimed at advancing AI-led transformations and cloud modernization across key industries like financial services, healthcare, utilities, and retail. The collaboration will expand EXL's AI solutions portfolio and support global market expansion, reinf…

b1BANK Names Ben Marmande Director of Corporate Banking

b1BANK Names Ben Marmande Director of Corporate Banking

b1BANK, a subsidiary of Business First Bancshares, Inc., announced the hiring of Ben Marmande as Director of Corporate Banking. Marmande brings over 40 years of banking experience and will lead the bank's corporate banking efforts in Texas, aiming to grow client acquisition, deepen client relationships, and expand commercial banking services. His e…

Ruanyun Edai Technology Establishes Saudi Regional Headquarters, Accelerating Global Expansion, AI Education Deployment and Transition

Ruanyun Edai Technology Establishes Saudi Regional Headquarters, Accelerating Global Expansion, AI Education Deployment and Transition

Ruanyun Edai Technology Inc. has launched its regional headquarters in Saudi Arabia, reinforcing its global expansion strategy and commitment to the Middle East and North Africa region. The company anticipates approximately 10% revenue growth in fiscal year 2026 driven by AI-powered education technologies and aims to derive 60% of revenues from glo…

SEGG Media Expands Soccerex Partnership, Positioning Sports.com at Center of Global Football Deal Ecosystem

SEGG Media Expands Soccerex Partnership, Positioning Sports.com at Center of Global Football Deal Ecosystem

Sports Entertainment Gaming Global Corporation (NASDAQ: SEGG) announced an expanded partnership with Soccerex, becoming the official headline sponsor for all Soccerex events in 2026 and 2027. This collaboration integrates Sports.com into Soccerex's global platform, providing access to key football industry stakeholders and commercial opportunities …

Seven-Month-Old Killed by Stray Gunfire in Brooklyn; Suspect in Custody

Seven-Month-Old Killed by Stray Gunfire in Brooklyn; Suspect in Custody

A 7-month-old girl riding in a stroller was shot and killed on a Brooklyn street during an apparent gang-related exchange of gunfire. City officials say the child was an unintended target; one suspect has been taken into custody and police continue to seek a second man seen fleeing the scene on a moped.

Administration Plans Steep Tariffs for Drugmakers Lacking U.S. Pricing Deals

Administration Plans Steep Tariffs for Drugmakers Lacking U.S. Pricing Deals

U.S. officials are preparing to announce tariffs on pharmaceutical companies that have not struck deals to guarantee lower prices domestically, with a potential 100% tariff on imported branded and patented medicines. Some multinational drugmakers have negotiated exemptions by committing to pricing arrangements and U.S. investment, while others have…